30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Mink Therapeutics Inc (INKT)

Track

Over the last 90 days, Mink Therapeutics Inc. has seen insider activity dominated by sales, totaling $19,141.25. There were two sell transactions, resulting in a net negative value and insider count. No executive transactions were recorded during this period. The company's stock has experienced a 28.0% increase in the past 90 days.
Stock chart
Ticker: INKT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ryan Barbara
2 sales — total 200,000 USD
Sale 4 Jun 2026
Value US$2,956,021.48 | Price 479.87 | Shares 56,082
Sale 4 Jun 2026
Value US$3,239,672.83 | Price 42.02 | Shares 51,171
Sale 10 Mar 2026
Value US$4,930,225.19 | Price 207.32 | Shares 35,476
Sale 10 Mar 2026
Value US$753,056.68 | Price 486.63 | Shares 73,928
Sale 10 Mar 2026
Value US$4,584.66 | Price 15.28 | Shares 300
Sale 9 Mar 2026
Value US$2,034.50 | Price 10.17 | Shares 200
Sale 2 Mar 2026
Value US$1,082.58 | Price 10.83 | Shares 100
Sale 27 Feb 2026
Value US$4,343.32 | Price 10.86 | Shares 400
Proposed sale 29 Aug 2025
Value US$12,572,265.00 | Price 15.98 | Shares 786,750
Buy 16 Oct 2023
Value US$471.56 | Price 1.10 | Shares 429
Buy 13 Oct 2023
Value US$21,310.30 | Price 1.10 | Shares 19,373
Buy 12 Oct 2023
Value US$3,488.40 | Price 1.10 | Shares 3,173
Buy 4 Oct 2023
Value US$16,379.59 | Price 1.09 | Shares 15,001
Buy 29 Aug 2023
Value US$45,015.59 | Price 1.52 | Shares 29,678
Buy 28 Aug 2023
Value US$18,570.32 | Price 1.45 | Shares 12,808
Buy 24 Aug 2023
Value US$262,907.81 | Price 1.54 | Shares 170,244
Buy 11 May 2023
Value US$33,347.83 | Price 1.43 | Shares 23,361
Buy 10 May 2023
Value US$33,296.08 | Price 1.51 | Shares 22,065
Buy 5 May 2023
Value US$250.00 | Price 1.25 | Shares 200
Buy 5 May 2023
Value US$94,850.00 | Price 0.95 | Shares 100,000
Sale 5 May 2023
Value US$94,850.00 | Price 0.95 | Shares 100,000
Buy 4 May 2023
Value US$26,246.45 | Price 1.22 | Shares 21,473
Buy 3 May 2023
Value US$138,842.56 | Price 1.08 | Shares 128,689
Buy 2 May 2023
Value US$94,850.00 | Price 0.95 | Shares 100,000
Buy 19 Jul 2022
Value US$23,208.77 | Price 1.39 | Shares 16,661
Buy 18 Jul 2022
Value US$4,437.53 | Price 1.33 | Shares 3,339
Buy 19 Oct 2021
Value US$16,800,000.00 | Price 12.00 | Shares 1,400,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04 S Sale
3.0
Ryan Barbara
Non-Executive Director
56,082 -9.2%
479.87
US$2,956,021 		56,082 -9.2% 479.87 US$2,956,021
2026-06-05 2026-06-04 S Sale
3.0
Ryan Barbara
Non-Executive Director
51,171 -29.1%
42.02
US$3,239,673 		51,171 -29.1% 42.02 US$3,239,673
2026-03-11 2026-03-10 S Sale
3.0
Ryan Barbara
Non-Executive Director
35,476 +17.6%
207.32
US$4,930,225 		35,476 +17.6% 207.32 US$4,930,225
2026-03-11 2026-03-10 S Sale
3.0
Ryan Barbara
Non-Executive Director
500 -2.3%
15.57
US$7,783 		500 -2.3% 15.57 US$7,783
2026-03-11 2026-03-10 S Sale
3.0
Ryan Barbara
Non-Executive Director
300 -1.4%
15.28
US$4,585 		300 -1.4% 15.28 US$4,585
2026-03-11 2026-03-09 S Sale
3.0
Ryan Barbara
Non-Executive Director
200 -0.9%
10.17
US$2,034 		200 -0.9% 10.17 US$2,034
2026-03-04 2026-03-02 S Sale
3.0
Ryan Barbara
Non-Executive Director
100 -0.5%
10.83
US$1,083 		100 -0.5% 10.83 US$1,083
2026-03-04 2026-02-27 S Sale
3.0
Ryan Barbara
Non-Executive Director
400 -1.8%
10.86
US$4,343 		400 -1.8% 10.86 US$4,343
2025-08-29 2025-08-29 PrS Proposed sale
2.5
Agenus Inc.

Owner
786,750
15.98
US$12,572,265 		786,750 15.98 US$12,572,265
2023-10-16 2023-10-16 B Purchase
2.5
AGENUS INC
Large shareholder
429 +0.0%
1.10
US$472 		429 +0.0% 1.10 US$472
2023-10-16 2023-10-13 B Purchase
2.5
AGENUS INC
Large shareholder
19,373 +0.1%
1.10
US$21,310 		19,373 +0.1% 1.10 US$21,310
2023-10-16 2023-10-12 B Purchase
2.5
AGENUS INC
Large shareholder
3,173 +0.0%
1.10
US$3,488 		3,173 +0.0% 1.10 US$3,488
2023-10-06 2023-10-04 B Purchase
2.5
AGENUS INC
Large shareholder
15,001 +0.1%
1.09
US$16,380 		15,001 +0.1% 1.09 US$16,380
2023-08-31 2023-08-29 B Purchase
2.5
AGENUS INC
Large shareholder
29,678 +0.1%
1.52
US$45,016 		29,678 +0.1% 1.52 US$45,016
2023-08-28 2023-08-28 B Purchase
2.5
AGENUS INC
Large shareholder
12,808 +0.1%
1.45
US$18,570 		12,808 +0.1% 1.45 US$18,570
2023-08-28 2023-08-24 B Purchase
2.5
AGENUS INC
Large shareholder
170,244 +0.8%
1.54
US$262,908 		170,244 +0.8% 1.54 US$262,908
2023-05-12 2023-05-11 B Purchase
2.5
AGENUS INC
Large shareholder
23,361 +0.1%
1.43
US$33,348 		23,361 +0.1% 1.43 US$33,348
2023-05-12 2023-05-10 B Purchase
2.5
AGENUS INC
Large shareholder
22,065 +0.1%
1.51
US$33,296 		22,065 +0.1% 1.51 US$33,296
2023-05-05 2023-05-05 B Purchase
2.5
AGENUS INC
Large shareholder
200 +0.0%
1.25
US$250 		200 +0.0% 1.25 US$250
2023-05-05 2023-05-05 B Purchase
2.5
AGENUS INC
Large shareholder
100,000 +0.5%
0.95
US$94,850 		100,000 +0.5% 0.95 US$94,850
2023-05-05 2023-05-05 S Sale
2.4
ARMEN GARO H
Non-Executive Director
100,000 -5.1%
0.95
US$94,850 		100,000 -5.1% 0.95 US$94,850
2023-05-05 2023-05-04 B Purchase
2.5
AGENUS INC
Large shareholder
21,473 +0.1%
1.22
US$26,246 		21,473 +0.1% 1.22 US$26,246
2023-05-05 2023-05-03 B Purchase
2.5
AGENUS INC
Large shareholder
128,689 +0.6%
1.08
US$138,843 		128,689 +0.6% 1.08 US$138,843
2023-05-04 2023-05-02 B Purchase
2.4
ARMEN GARO H
Non-Executive Director
100,000 +5.3%
0.95
US$94,850 		100,000 +5.3% 0.95 US$94,850
2022-07-21 2022-07-19 B Purchase
3.4
WIINBERG ULF
Non-Executive Director
16,661 +5.9%
1.39
US$23,209 		16,661 +5.9% 1.39 US$23,209
2022-07-21 2022-07-18 B Purchase
3.4
WIINBERG ULF
Non-Executive Director
3,339 +1.2%
1.33
US$4,438 		3,339 +1.2% 1.33 US$4,438
2021-10-20 2021-10-19 B Purchase
2.5
AGENUS INC
Large shareholder
1,400,000 +7.2%
12.00
US$16,800,000 		1,400,000 +7.2% 12.00 US$16,800,000
Explore more

More insider trading research around Mink Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America